The Midas Touch: How Zydus Lifesciences Yielded 5449% Returns

If you had ₹1 lakh invested in December 2002, you could have had ₹69.54 lakhs today! This multibagger gave its investors returns of ₹54,49,660 and dividends of ₹14,04,612. Here’s a quick look at the company.

💊 Stock Name: Zydus Lifesciences Ltd.
💊 NSE: $ZYDUSLIFE

⭐ About The Company
Zydus Lifesciences is in the field of pharmaceuticals, primarily engaged in manufacturing generic medicines. Founded in the year 1952, the company was founded by Ramanbhai Patel, a former professor at the L.M. College of Pharmacy and his business partner Indravadan Modi. Formerly, the company was known as Cadila Healthcare. The company is headquartered in Ahmedabad.

Zydus has built a strong network of facilities and caters to a broad customer base of 23,000 clients.

The company has:
💉 3 business sites in Mumbai and Ahmedabad
💉 6 production plants in Gujarat, Sikkim, Maharashtra, Goa and Himachal Pradesh
💉 2 state-of-the-art R&D facilities in Vadodara and Ahmedabad

On the international front:
💉 14 business sites across the globe in countries like the USA, Kenya and Myanmar
💉 4 manufacturing facilities in the USA, Brazil and Myanmar
💉 2 R&D sites in the USA and Italy

The company is one of the leading exporters of pharmaceutical products in more than 25 emerging economies, most of which are in Latin America and South Africa.

🏆 Awards & Accolades
Ranked 100th in the Fortune India 500 list in 2020, Zydus Lifesciences is the 4th largest company in the pharmaceutical industry in India. For its contribution to the enrichment of healthcare across the world, the company has received a number of awards and accolades. In 2022, ETHealthworld India Pharmaworld Awards 2022 crowned Zydus Lifesciences as the ‘Pharma Company Of The Year’ award. Additionally, it received the IDMA Corporate Citizen Award in 2021.

💰 Stock Value
On December 6, 2002, the company’s shares were trading at ₹7.45, while they were priced at ₹413.45 as of December 5, 2022.